20.500.12556/DiRROS-14941 Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : an initiative of the Central European Cooperative Oncology Group (CECOG) o establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). Methods: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. Results: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). Conclusion: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‑2 (severe acute respiratory syndrome coronavirus type 2) pandemic. CECOG Osrednja in jugovzhodna Evropa nadzorni imunski zaviralci maligne bolezni CECOG Central and Southeastern Europe immune checkpoint inhibitors malignant diseases true false true Springer Nature Angleški jezik Ni določen © The Author(s) Neznano 2022-03-31 13:10:23 2022-03-31 13:10:25 2022-08-21 03:34:12 0000-00-00 00:00:00 2022 0 Avstrija 0 Soavtorice iz Slovenije: Cvetka Grašič Kuhar, Marina Mencinger, Urška Janžič; str. [1-8] no. Vol. 2022 0000-00-00 Zaloznikova VTisku NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-006 0043-5325 10.1007/s00508-022-02016-z 102525955 s00508-022-02016-z.pdf s00508-022-02016-z.pdf 1 F6D526A31B618E9D49B935C799F7E617 38f6e39ac45f3466a58f67d3368e3d5da04025e4bd4866cd937967d272002c05 e066ca9a-17b6-11ed-b6b8-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=19401 https://link.springer.com/content/pdf/10.1007/s00508-022-02016-z.pdf 1 https://dirros.openscience.si/Dokument.php?lang=slv&id=19402 Univerzitetna klinika za pljučne bolezni in alergijo Golnik 0 0 0